← Back to Search

Pacemaker

Aveir VR Leadless Pacemaker for Arrhythmia

N/A
Waitlist Available
Research Sponsored by Abbott Medical Devices
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing the safety and effectiveness of the Aveir LP System, a pacemaker for patients with slow heart rhythms. The device helps the heart maintain a regular beat by sending electrical signals.

Eligible Conditions
  • Arrhythmia
  • Bradycardia
  • Slow Heart Rate

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Aveir VR Leadless PacemakerExperimental Treatment1 Intervention
VVIR pacing

Find a Location

Who is running the clinical trial?

Abbott Medical DevicesLead Sponsor
650 Previous Clinical Trials
416,017 Total Patients Enrolled
8 Trials studying Arrhythmia
3,684 Patients Enrolled for Arrhythmia
~65 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top